Personalized drug strategy aims to control Tough-to-Treat blood cancer
NCT ID NCT05478512
Summary
This study is testing a personalized treatment plan for young adults with a high-risk form of chronic lymphocytic leukemia (CLL), a type of blood cancer. All participants start with a two-drug combination. Their treatment path is then customized based on how much cancer remains in their body. Some participants may stop treatment early, while others continue with different drug combinations to try to control the disease long-term.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ematologia AO di Perugia
Perugia, Italy
-
Ematologia AOU Careggi
Florence, Italy
-
Ematologia AOUS - Policlinico S. M. alle Scotte
Siena, Italy
-
Ematologia IRST D.Amadori
Meldola, Italy
-
Ematologia Ospedale Infermi
Rimini, Italy
-
Ematologia Ospedale S.M. delle Croci
Ravenna, Italy
-
Ematologia Policlinico Gemelli
Roma, Italy
-
Ematologia Policlinico Umberto I
Roma, Italy
Conditions
Explore the condition pages connected to this study.